Innovations on show at European Respiratory Society International Congress 2015
Philips Respironics, a division of Royal Philips, showcased its latest portfolio of sleep-disordered breathing and respiratory solutions at the recent European Respiratory Society International Congress in Amsterdam.
Clinicians were able to experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.
Philips’ sleep therapy portfolio connects the provider and the patient at the most-important points in the care continuum, from diagnosis to compliance and ongoing use and resupply.
The following new sleep-disordered breathing solutions were on display:
“As a leader in sleep apnea treatment innovation, Philips continuously aims to expand its CPAP mask offerings with an emphasis on patient comfort,” said Mark D’Angelo, sleep business leader at Philips.
“By addressing patient concerns, like limited mobility and mask-related irritation, we can provide patients with more personalised options to help them adapt to and stick with their OSA treatment, and get the sleep they deserve.
“Philips Respironics is committed to providing one unified approach to COPD care – co-ordinated, consistent, uninterrupted and centered around the patient and the home. Our goal is to help reduce hospitalisations, improve patient care, maximise clinician resources and support patients in living more-active, fulfilling lives.
Respiratory solutions on display at the show included: